Can Axon Boosts Margin Performance Amid Cost Pressures?

Axon reported first-quarter 2026 adjusted EBITDA of $201.6 million, up 29.9% year over year, but adjusted EBITDA margin slipped 70 bps to 25.0% and adjusted gross margin fell 200 bps to 61.6% amid higher operating costs, tariffs, and R&D spending. Revenue grew 33.7%, yet cost of sales rose 38.8% and SG&A increased 15.9%, highlighting margin pressure despite strong top-line growth. Management still guides to roughly 25.5% adjusted EBITDA margin for 2026 and about 28% by 2028 on $6 billion of revenue.

Analysis

AXON is still the cleaner secular compounder in the group, but the quarter shows a subtle inflection: revenue can outrun cost pressure for a while, yet incremental gross margin compression from tariffs and R&D intensity is now visible. That matters because this is a premium multiple stock already priced for durable operating leverage; when margin expansion pauses, the stock becomes much more sensitive to any guide-down or estimate drift over the next 1-2 quarters.

The second-order read is that AXON’s pricing power is probably intact, but not enough to fully offset supply-chain and product-mix friction in the near term. If tariffs persist, the pain is likely to show up first in hardware-heavy bookings and later in mix, while the software and cloud attach rate becomes the key defense for 2026-2028 margin goals. That makes the long-dated target credible only if software penetration continues to rise faster than device revenue, otherwise the 28% EBITDA margin target risks becoming a back-half-2027 story rather than a clean 2028 endpoint.

Relative to peers, KTOS looks most vulnerable because defense names with thinner margins and more program concentration typically absorb cost inflation with less pricing flexibility. WWD appears better insulated given the mix/support from commercial services and defense OEM demand, so the more interesting relative-value expression is not “short defense,” but “short lower-quality margin profiles vs long operating leverage.” The market’s mild negative estimate revision on AXON suggests consensus is not yet fully accounting for how sticky tariff-related input costs can be in a high-growth hardware/software hybrid.

Contrarian view: the move may be overdone on the downside if investors assume margin pressure is linear. AXON can re-accelerate operating leverage quickly if R&D spend normalizes and software revenue overtakes the hardware base; in that case, the current multiple can still be justified despite near-term margin noise. The real catalyst to watch is whether the next two quarters show gross margin stabilization, not just revenue growth, because that is what will determine whether this is a temporary digestion phase or the start of multiple compression.

Key Decisions for Investors

• Hold AXON, but trim into strength: prefer using 1-2 quarter earnings windows to monetize upside while the stock still trades on premium growth expectations; risk/reward worsens if gross margin fails to stabilize.
• Buy AXON on a post-earnings pullback only if management reiterates 2026 margin guidance and confirms software attach-rate improvement; target a 6-9 month horizon with asymmetric upside if margins stop contracting.
• Pair trade: long WWD / short KTOS for the next 3-6 months. WWD has better cost absorption and mix support, while KTOS looks more exposed to persistent input-cost pressure and weaker margin conversion.
• If using options on AXON, favor call spreads over outright calls for the next 2 quarters: premium valuation reduces edge on delta-only upside, while a spread captures upside if the market re-prices margin durability.
• Set a risk trigger on AXON: if forward estimates keep drifting lower over the next 60 days and gross margin remains below ~62%, reduce exposure; that would signal the market is starting to doubt the 2028 margin path.